Cogent Biosciences, Inc.
- Stock
- Ticker COGT
- Nasdaq
Performance, volatility and drawdowns of Cogent Biosciences, Inc. since 03/2018, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $31,504. Global equities (VT): $14,653.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −98.1% in 03/2020, measured from the peak in 07/2018. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Operating income | -74 | -75 | -76 | -83 | -99 | -104 | -103 | -117 |
| EBITDA | -73 | -74 | -75 | -83 | -99 | -103 | -102 | -117 |
| Net income | -68 | -72 | -74 | -81 | -102 | -97 | -96 | -111 |
| Earnings per share | -0.50 | -0.52 | -0.53 | -0.50 | -0.61 | -0.53 | -0.52 | -0.59 |
| Balance sheet | ||||||||
| Total assets | 328 | 284 | 275 | 426 | 938 | 903 | 835 | 832 |
| Liabilities | 72 | 65 | 120 | 123 | 301 | 295 | 302 | 316 |
| Equity | 256 | 219 | 155 | 302 | 636 | 608 | 532 | 516 |
| Cash | 98 | 126 | 128 | 125 | 312 | 241 | 181 | 217 |
| Long-term debt | 0.0 | – | 44 | 44 | 223 | 223 | 223 | 224 |
| Cash flow | ||||||||
| Operating cash flow | -61 | -67 | -55 | -64 | -79 | -87 | -77 | -81 |
| Capital expenditure | -0.1 | -0.5 | -0.1 | -0.1 | -0.8 | -0.4 | -0.4 | -0.1 |
| Free cash flow | -61 | -67 | -55 | -64 | -80 | -87 | -78 | -81 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2025 at +355.4%, weakest 2019 at −83.6%. 4 of 7 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 5 Nov 2026 | −$0.59 |
| 10 Aug 2026 | −$0.52 |
| 5 May 2026 | −$0.53 |
| 17 Feb 2026 | −$0.61 |
| 7 Nov 2025 | −$0.50 |
| 5 Aug 2025 | −$0.53 |
| 6 May 2025 | −$0.52 |
| 25 Feb 2025 | −$0.50 |
| 12 Nov 2024 | −$0.52 |
| 6 Aug 2024 | −$0.43 |
| 7 May 2024 | −$0.49 |
| 26 Feb 2024 | −$0.15 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €4.2bn
- Market cap in trading currency
- $4.65bn
- Enterprise value
- $4.08bn
- P/E
- –
- P/S
- –
- P/B
- 9.00
- EV/Sales
- –
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -7.0%
Results (last four quarters)
- Revenue
- –
- Gross profit
- –
- EBITDA
- −$420m
- Net income
- −$408m
- Earnings per share
- −$2.25
- Revenue per share
- –
- Revenue growth
- –
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity
- -99.6%
- Return on assets
- -49.0%
Balance sheet and cash flow
- Cash
- $791m
- Cash per share
- $4.55
- Financial debt
- $224m
- Debt/equity %
- 43
- Current ratio
- 10.99
- Book value per share
- $2.97
- Operating cash flow
- −$324m
- Free cash flow
- −$326m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 174m
- Volume
- 2.11m
- Avg. volume 3 months
- 2.03m
- Relative volume
- 1.0
Price and technicals
- Price
- $26.72
- 1 day
- −3.7%
- 52-week high
- $42.84
- 52-week low
- $26.72
- Distance to 52-week high
- −37.6%
- Distance to 52-week low
- 0.0%
- Distance to 50-day line
- −13.0%
- Distance to 200-day line
- −23.8%
- RSI (14)
- 36
- Volatility 1M
- 60.9%
Performance
- 1 week
- −6.5%
- 1 month
- −14.7%
- 3 months
- −26.3%
- 6 months
- −18.2%
- YTD
- −24.8%
- 1 year
- −23.5%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has COGT performed since 03/2018?
$10,000 grew to $6,011 by 20 Nov 2026, which is −5.7% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is COGT?
Volatility was 187.0% per year, measured on monthly returns. The largest decline from a peak was −98.1%, with the low in 03/2020.
How does COGT compare with a broad equity ETF?
Over the same period Global equities (VT) returned +10.1% per year at 16.0% volatility, COGT returned −5.7% at 187.0%. The correlation of monthly returns was 0.14; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.